Versatile and multivalent nanobodies efficiently neutralize SARS-CoV-2
Report
[키워드] acute respiratory syndrome
affinity
Anti-spike
antibody
Bacteria
cells
complex
Concentration
coronavirus
COVID-19 pandemic
group
half-maximal inhibitory concentration
identify
immunization
inactive
indicated
inhibit
intravenously
mammalian cell
mechanisms
microbe
multivalent
nanobodies
nanobody
neutralization
neutralization potency
neutralize
Neutralizing
nonoverlapping epitope
potent
Prevent
produced
proteomics
RBD
Receptor binding domain
SARS-CoV-2
Science
screened
selected
Spike protein
stability
synthetic nanobody
the RBD
the spike protein
therapeutic
viral infection
yeast
[DOI] 10.1126/science.abe4747 PMC 바로가기 [Article Type] Report
[DOI] 10.1126/science.abe4747 PMC 바로가기 [Article Type] Report